Skip to main content

Table 1 Baseline characteristics of the study population

From: Impaired left atrial reservoir and conduit strain in patients with atrial fibrillation and extensive left atrial fibrosis

 

AF patients (n = 94)

Healthy controls (n = 19)

P-value

Demographics

 Age, years

60 ± 9

58 ± 4

0.21

 Male gender

60 (64%)

11 (58%)

0.63

 Weight (kg)

84 ± 14

80 ± 12

0.44

 Height (cm)

180 ± 11

176 ± 8

0.15

 BMI (kg/m2)

25.9 ± 3.4

25.6 ± 5.1

0.84

 BSA (Mosteller)*

2.0 ± 0.2

2.0 ± 0.2

0.48

 CHA2DS2-VASc score

1.2 ± 1.2

 Hypertension

30 (32%)

Diabetes mellitus

4 (4%)

Medications

 ACE inhibitor or ARB

29 (30.9%)

 Spironolactone

3 (3.2%)

 Amiodarone

10 (11.0%)

 Anticoagulation

77 (81.9%)

AF history

 Paroxysmal AF

62 (66%)

 Persistent AF

32 (34%)

 Time between AF diagnosis and CMR (months)

32 (14–83)

  1. Values are expressed as number (percentage), mean ± SD or median (25–75th percentile). ACE angiotensin-converting-enzyme, ARB Angiotensin-receptor-blocker, AF atrial fibrillation, BMI body mass index, BSA body surface area, CHA2DS2VASc history of congestive heart failure, hypertension, diabetes mellitus, stroke/transient ischemic attack/prior thromboembolism, vascular disease, age and sex, CMR cardiovascular magnetic resonance. *Calculated by the Mosteller method ((height (cm) x weight (kg)/3600)½)